Market's Volatility | Cabot Weekly Review

The stock charts used in this presentation are provided by WONDA ® Copyright © 2016 William O’Neil + Co., Inc. All rights reserved. Unauthorized duplication, modification, photocopying or distribution in any form is strictly prohibited.

In today’s market video, Emerging Markets Investor Chief Analyst Paul Goodwin surveys the damage from the market’s continuing January plunge. There are plenty of reasons for the correction, China chief among them, but the reasons aren’t that important. The urgent advice is to commit yourself to protecting the value of your growth portfolio by selling losers, taking partial profits in winners and reducing new buying to a minimum. It’s a hard market to make any money in. Paul gives a few stocks that are on his watch list for future consideration, but advises that you keep your finger away from that “Buy” button.

Stock Picks

Loews Corp.

This undervalued stock has strong future earnings growth expectations.

Biogen

Biogen is the market-share leader in treating multiple sclerosis.

Weibo

One of Paul Godwin’s favorite stocks in his Cabot Emerging Markets Investor portfolio.

Cabot Wealth Advisory

Does Alibaba (BABA) Stock Measure Up to Amazon (AMZN)?

By Paul Goodwin on September 23, 2016

Alibaba (BABA) is the Amazon (AMZN) of China. But does BABA stock measure up to AMZN stock? Let’s break it down!Read More >

As Stock Market Trends Change, Invest in these New Leaders

By Michael Cintolo on September 22, 2016

History tells us that all stock market trends change, and if you don’t recognize the leaders of that change early, you risk missing out on the next big winners.Read More >

AMZN Stock vs. FB Stock: Which Is the Better Value Buy?

By J. Royden Ward on September 20, 2016

For the past five years, AMZN stock and FB stock have been two of the market's great growth stories. But could you make the case that either stock is still undervalued? Let’s break it down.Read More >